Home1795 • TPE
add
Lotus Pharmaceutical Co Ltd
Previous close
$236.50
Day range
$236.00 - $239.00
Year range
$172.50 - $323.00
Market cap
63.00B TWD
Avg Volume
1.53M
P/E ratio
11.44
Dividend yield
-
Primary exchange
TPE
Market news
Financials
Income Statement
Revenue
Net income
(TWD) | Mar 2025info | Y/Y change |
---|---|---|
Revenue | 4.73B | 12.66% |
Operating expense | 1.20B | 14.57% |
Net income | 1.44B | 38.52% |
Net profit margin | 30.35 | 22.97% |
Earnings per share | 5.47 | 38.83% |
EBITDA | 2.03B | 32.10% |
Effective tax rate | 17.62% | — |
Balance Sheet
Total assets
Total liabilities
(TWD) | Mar 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 5.60B | 79.56% |
Total assets | 40.67B | 18.62% |
Total liabilities | 19.47B | 13.65% |
Total equity | 21.20B | — |
Shares outstanding | 265.35M | — |
Price to book | 2.96 | — |
Return on assets | 10.61% | — |
Return on capital | 12.53% | — |
Cash Flow
Net change in cash
(TWD) | Mar 2025info | Y/Y change |
---|---|---|
Net income | 1.44B | 38.52% |
Cash from operations | 2.73B | 54.64% |
Cash from investing | -1.85B | -364.47% |
Cash from financing | -1.32B | -2,097.55% |
Net change in cash | -425.20M | -131.48% |
Free cash flow | 1.80B | -22.64% |
About
Founded
1966
Website
Employees
1,099